These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 37666725

  • 1. The role of bariatric surgery on beta-cell function and insulin resistance in patients with nonalcoholic fatty liver disease and steatohepatitis.
    Poljo A, Kopf S, Sulaj A, Roessler S, Albrecht T, Goeppert B, Bojko S, Müller-Stich BP, Billeter AT.
    Surg Obes Relat Dis; 2023 Dec; 19(12):1421-1434. PubMed ID: 37666725
    [Abstract] [Full Text] [Related]

  • 2. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A, Elahmedi M, Alswat K, Arafah M, Fagih M, Lee J.
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [Abstract] [Full Text] [Related]

  • 3. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [Abstract] [Full Text] [Related]

  • 4. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
    Cherla DV, Rodriguez NA, Vangoitsenhoven R, Singh T, Mehta N, McCullough AJ, Brethauer SA, Schauer PR, Aminian A.
    Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic Surgery.
    Russo MF, Lembo E, Mari A, Angelini G, Verrastro O, Nanni G, Pompili M, Raffaelli M, Vecchio FM, Bornstein SR, Mingrone G.
    J Clin Endocrinol Metab; 2021 Mar 08; 106(3):750-761. PubMed ID: 33248441
    [Abstract] [Full Text] [Related]

  • 8. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
    Wei L, Li M, Zeng N, Liu Y, Bai R, Zhang N, Song J, Zhang P, Yao Q, Yang Z, Zhao X, Zhang Y, Zhang P, Zhang Z.
    BMC Surg; 2021 Jun 24; 21(1):298. PubMed ID: 34167531
    [Abstract] [Full Text] [Related]

  • 9. Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis.
    Chatterjee A, Basu A, Das K, Singh P, Mondal D, Bhattacharya B, Roychoudhury S, Majumder PP, Chowdhury A, Basu P.
    Ann Hepatol; 2020 Jun 24; 19(5):472-481. PubMed ID: 32682086
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.
    Siddiqui MS, Cheang KL, Luketic VA, Boyett S, Idowu MO, Patidar K, Puri P, Matherly S, Stravitz RT, Sterling RK, Sanyal AJ.
    Dig Dis Sci; 2015 Aug 24; 60(8):2529-37. PubMed ID: 25784075
    [Abstract] [Full Text] [Related]

  • 12. Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
    Kalavalapalli S, Leiva EG, Lomonaco R, Chi X, Shrestha S, Dillard R, Budd J, Romero JP, Li C, Bril F, Samraj G, Pennington J, Townsend P, Orlando F, Shetty S, Mansour L, Silva-Sombra LR, Bedossa P, Malaty J, Barb D, Gurka MJ, Cusi K.
    J Clin Endocrinol Metab; 2023 Apr 13; 108(5):1192-1201. PubMed ID: 36378995
    [Abstract] [Full Text] [Related]

  • 13. NASH-related increases in plasma bile acid levels depend on insulin resistance.
    Grzych G, Chávez-Talavera O, Descat A, Thuillier D, Verrijken A, Kouach M, Legry V, Verkindt H, Raverdy V, Legendre B, Caiazzo R, Van Gaal L, Goossens JF, Paumelle R, Francque S, Pattou F, Haas JT, Tailleux A, Staels B.
    JHEP Rep; 2021 Apr 13; 3(2):100222. PubMed ID: 33615207
    [Abstract] [Full Text] [Related]

  • 14. A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.
    Ramos-Molina B, Castellano-Castillo D, Pastor O, Ocaña-Wilhelmi L, Fernández-García D, Romero-Gómez M, Cardona F, Tinahones FJ.
    Obes Surg; 2019 Mar 13; 29(3):983-989. PubMed ID: 30488259
    [Abstract] [Full Text] [Related]

  • 15. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP, Rigbolt KTG, Veidal SS, Heebøll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK.
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr 01; 316(4):G462-G472. PubMed ID: 30653341
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery.
    Goossens N, Hoshida Y, Song WM, Jung M, Morel P, Nakagawa S, Zhang B, Frossard JL, Spahr L, Friedman SL, Negro F, Rubbia-Brandt L, Giostra E.
    Clin Gastroenterol Hepatol; 2016 Nov 01; 14(11):1619-1628. PubMed ID: 26492845
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.
    Verrastro O, Panunzi S, Castagneto-Gissey L, De Gaetano A, Lembo E, Capristo E, Guidone C, Angelini G, Pennestrì F, Sessa L, Vecchio FM, Riccardi L, Zocco MA, Boskoski I, Casella-Mariolo JR, Marini P, Pompili M, Casella G, Fiori E, Rubino F, Bornstein SR, Raffaelli M, Mingrone G.
    Lancet; 2023 May 27; 401(10390):1786-1797. PubMed ID: 37088093
    [Abstract] [Full Text] [Related]

  • 20. Noninvasive assessment of hepatic steatosis and fibrosis in patients with severe obesity.
    Coccia F, Testa M, Guarisco G, Bonci E, Di Cristofano C, Silecchia G, Leonetti F, Gastaldelli A, Capoccia D.
    Endocrine; 2020 Mar 27; 67(3):569-578. PubMed ID: 31858390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.